อ้างอิง ของ โอมีปราโซล

  1. 1 2 3 4 5 6 7 8 9 10 "Omeprazole". The American Society of Health-System Pharmacists. Archived from the original on 2015-09-24. สืบค้นเมื่อ 2015-12-01.
  2. ↑ "Prilosec Prescribing Information" (PDF). AstraZeneca Pharmaceuticals. Archived from the original (PDF) on 2010-02-16.
  3. ↑ Vaz-Da-Silva, M; Loureiro, AI; Nunes, T; Maia, J; Tavares, S; Falcão, A; Silveira, P; Almeida, L; Soares-Da-Silva, P (2005). "Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions". Clinical Drug Investigation. 25 (6): 391–9. doi:10.2165/00044011-200525060-00004. PMID 17532679. Archived from the original on 2013-03-13.
  4. ↑ "omeprazole_msds".
  5. ↑ "Omeprazole 40 mg Powder for Solution for Infusion". EMC. 2016-02-10. Archived from the original on 2016-04-07. สืบค้นเมื่อ 2016-03-29.
  6. ↑ Fischer, edited by János; Ganellin, C. Robin (2006). Analogue-based drug discovery. Weinheim: Wiley-VCH. p. 88. ISBN 9783527607495. Archived from the original on 2016-03-05.CS1 maint: Extra text: authors list (link)
  7. ↑ "WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. 2015-04. Archived (PDF) from the original on 2016-12-013. สืบค้นเมื่อ 2016-12-08. Check date values in: |date=, |archivedate= (help)
  8. ↑ "Omeprazole". International Drug Price Indicator Guide. Archived from the original on 2017-05-10. สืบค้นเมื่อ 2015-12-01.
  9. ↑ "NADAC as of 2016-11-16 Data.Medicaid.gov". Centers for Medicare and Medicaid Services. Archived from the original on 2016-11-17.
  10. ↑ Cheng, Edaire (2013-07). "Proton Pump Inhibitors for Eosinophilic Esophagitis". Current Opinion in Gastroenterology. 29 (4): 416–420. doi:10.1097/MOG.0b013e32835fb50e. ISSN 0267-1379. PMC 4118554. PMID 23449027. Check date values in: |date= (help)
  11. ↑ Fuccio, L; Minardi, M. E.; Zagari, R. M.; Grilli, D; Magrini, N; Bazzoli, F (2007). "Meta-analysis: Duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication". Annals of Internal Medicine. 147 (8): 553–62. doi:10.7326/0003-4819-147-8-200710160-00008. PMID 17938394.
  12. ↑ Malfertheiner, P; Megraud, F; O'Morain, C; Bazzoli, F; El-Omar, E; Graham, D; Hunt, R; Rokkas, T; Vakil, N; Kuipers, EJ (2007-06). "Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report". Gut. 56 (6): 772–81. doi:10.1136/gut.2006.101634. PMC 1954853. PMID 17170018. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  13. ↑ McTavish, D; Buckley, MM; Heel, RC (1991). "Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders". Drugs. 42 (1): 138–70. doi:10.2165/00003495-199142010-00008. PMID 1718683.CS1 maint: Uses authors parameter (link)
  14. ↑ Abou Chakra, CN; และคณะ (2014-06). "Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review". PLoS ONE. 9 (6): e98400. Bibcode:2014PLoSO...998400A. doi:10.1371/journal.pone.0098400. PMC 4045753. PMID 24897375. Check date values in: |date= (help)
  15. ↑ Yang, Yu-Xiao; และคณะ (2006). "Long-term proton pump inhibitor therapy and risk of hip fracture". JAMA. 296 (24): 2947–2953. doi:10.1001/jama.296.24.2947. PMID 17190895.
  16. ↑ Yu, Elaine W.; และคณะ (2011). "Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies". The American Journal of Medicine. 124 (6): 519–526. doi:10.1016/j.amjmed.2011.01.007. PMC 3101476. PMID 21605729.
  17. ↑ Hess, M. W.; และคณะ (2012). "Systematic review: hypomagnesaemia induced by proton pump inhibition". Alimentary pharmacology & therapeutics. 36 (5): 405–413. doi:10.1111/j.1365-2036.2012.05201.x.
  18. ↑ Neal, Keith; Logan, Richard (2001). "Potential gastrointestinal effects of long‐term acid suppression with proton pump inhibitors". Alimentary pharmacology & therapeutics. 15 (7): 1085–1085. doi:10.1046/j.1365-2036.2001.0994a.x. PMID 11421886.
  19. ↑ Sarzynski, Erin; และคณะ (2011). "Association between proton pump inhibitor use and anemia: a retrospective cohort study". Digestive diseases and sciences. 56 (8): 2349–2353. doi:10.1007/s10620-011-1589-y. PMID 21318590.
  20. ↑ McColl, Kenneth EL (2009). "Effect of proton pump inhibitors on vitamins and iron". The American Journal of Gastroenterology. 104: S5–S9. doi:10.1038/ajg.2009.45. PMID 19262546.
  21. ↑ Härmark, Linda; และคณะ (2007). "Proton pump inhibitor‐induced acute interstitial nephritis". British Journal of Clinical Pharmacology. 64 (6): 819–823. doi:10.1111/j.1365-2125.2007.02927.x. PMC 2198775. PMID 17635502.
  22. ↑ Corleto, V.D. (2014-02). "Proton pump inhibitor therapy and potential long-term harm". Curr Opin Endocrinol Diabetes Obes. 21 (1): 3–8. doi:10.1097/med.0000000000000031. PMID 24310148. Check date values in: |date= (help)
  23. ↑ Eusebi, LH; Rabitti, S; Artesiani, ML; Gelli, D; Montagnani, M; Zagari, RM; Bazzoli, F (2017-07). "Proton pump inhibitors: Risks of long-term use". Journal of Gastroenterology and Hepatology. 32 (7): 1295–1302. doi:10.1111/jgh.13737. PMID 28092694. Check date values in: |date= (help)
  24. ↑ Pasternak, Björn; Hviid, Anders (2010). "Use of Proton-Pump Inhibitors in Early Pregnancy and the Risk of Birth Defects". New England Journal of Medicine. 363 (22): 2114–23. doi:10.1056/NEJMoa1002689. PMID 21105793.
  25. ↑ "Omeprazole drug summary". PDR.net. Archived from the original on 2014-03-03. สืบค้นเมื่อ 2014-03-03.
  26. ↑ "LACTMED: OMEPRAZOLE". 2015-03-10. Archived from the original on 2017-09-08. สืบค้นเมื่อ 2015-12-01.
  27. ↑ Fitzakerley, Janet (2014-01-05). "2014 Treatments for Acid-Peptic Diseases: PPIs Side Effects". University of Minnesota Medical School Duluth. Archived from the original on 2014-04-19.CS1 maint: Uses authors parameter (link)
  28. ↑ "Proton Pump Inhibitor: Use in Adults" (PDF). CMS Medicaid Integrity Program. 2013-08. Archived from the original (PDF) on 2013-12-012. Check date values in: |date=, |archivedate= (help)
  29. ↑ Douglas, I. J.; Evans, S. J.; Hingorani, A. D.; Grosso, A. M.; Timmis, A; Hemingway, H; Smeeth, L (2012). "Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs". BMJ. 345: e4388. doi:10.1136/bmj.e4388. PMC 3392956. PMID 22782731.
  30. ↑ Focks, J. J.; Brouwer, M. A.; Van Oijen, M. G. H.; Lanas, A.; Bhatt, D. L.; Verheugt, F. W. A. (2012). "Concomitant use of clopidogrel and proton pump inhibitors: Impact on platelet function and clinical outcome- a systematic review". Heart. 99 (8): 520–7. doi:10.1136/heartjnl-2012-302371. PMID 22851683.
  31. ↑ Shirasaka, Y; Sager, J. E.; Lutz, J. D.; Davis, C; Isoherranen, N (2013-07). "Inhibition of CYP2C19 and CYP3A4 by Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions". Drug Metab. Dispos. 41 (7): 1414–24. doi:10.1124/dmd.113.051722. PMC 3684819. PMID 23620487. Check date values in: |date= (help)
  32. ↑ Lau, WC; Gurbel, PA (2009-03). "The drug-drug interaction between proton pump inhibitors and clopidogrel". CMAJ. 180 (7): 699–700. doi:10.1503/cmaj.090251. PMC 2659824. PMID 19332744. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  33. ↑ Norgard, NB; Mathews, KD; Wall, GC (2009-07). "Drug-drug interaction between clopidogrel and the proton pump inhibitors". Ann Pharmacother. 43 (7): 1266–1274. doi:10.1345/aph.1M051. PMID 19470853. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  34. ↑ Torkamani, Ali. "Selective Serotonin Reuptake Inhibitors and CYP2D6". Medscape.com. Archived from the original on 2015-05-09.
  35. ↑ Daly, AK; King, BP (2003-05). "Pharmacogenetics of oral anticoagulants". Pharmacogenetics. 13 (5): 247–52. doi:10.1097/00008571-200305000-00002. PMID 12724615. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  36. 1 2 Stedman, CA; Barclay, ML (2000-08). "Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors". Aliment Pharmacol Ther. 14 (8): 963–978. doi:10.1046/j.1365-2036.2000.00788.x. PMID 10930890. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  37. ↑ Pauli-Magnus, C; Rekersbrink, S; Klotz, U; Fromm, MF (2001-12). "Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein". Naunyn Schmiedebergs Arch Pharmacol. 364 (6): 551–557. doi:10.1007/s00210-001-0489-7. PMID 11770010. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  38. ↑ Izzo, AA; Ernst, E (2009). "Interactions between herbal medicines and prescribed drugs: an updated systematic review". Drugs. 69 (13): 1777–1798. doi:10.2165/11317010-000000000-00000. PMID 19719333.
  39. ↑ Brayfield, A, ed. (2014-01-06). "Methotrexate". Martindale: The Complete Drug Reference. Pharmaceutical Press. สืบค้นเมื่อ 2014-04-12.
  40. ↑ "DrugBank: Omeprazole (DB00338)". Drugbank.ca. Archived from the original on 2014-02-05. สืบค้นเมื่อ 2014-02-24.
  41. ↑ "Omeprazole [package insert]". India: Dr. Reddy's Laboratories Limited. Archived from the original on 2014-04-19. Revised: 0613.
  42. ↑ Katz, PO; Gerson, LB; Vela, MF (2013). "Guidelines for the diagnosis and management of gastroesophageal reflux disease". Am J Gastroenterol. 108 (3): 308–28. doi:10.1038/ajg.2012.444. PMID 23419381.
  43. 1 2 "Zegerid (Omeprazole, Sodium Bicarbonate) Patient Information, Side Effects". RxList. 2013-02-14. สืบค้นเมื่อ 2018-07-26.
  44. ↑ "Omeprazole, in The Free Medical Dictionary". สืบค้นเมื่อ 2010-11-11.
  45. ↑ "Omeprazole". Drugs.com. Archived from the original on 2011-02-19. สืบค้นเมื่อ 2010-11-11.
  46. ↑ "Omeprazole". MIMS Malaysia. สืบค้นเมื่อ 2018-07-30. Cap: Should be taken with food. Take immediately before a meal. Mups Tab: May be taken with or without food.
  47. ↑ Baselt, RC (2008). Disposition of Toxic Drugs and Chemicals in Man (8th ed.). Foster City, CA: Biomedical Publications. pp. 1146–7.CS1 maint: Uses authors parameter (link)
  48. 1 2 Farley, D (July–August 1995). "Making it easier to read prescriptions". FDA Consum. 29 (6): 25–7. PMID 10143448. Archived from the original on 2012-03-15.CS1 maint: Date format (link)
  49. ↑ Harris, Gardiner (2002-06-06). "Prilosec's Maker Switches Users To Nexium, Thwarting Generics". The Wall Street Journal. Archived from the original on 2017-08-06.
  50. ↑ Aubert, Jerome; Mulder, Chris JJ; Schrör, Karsten; Vavricka, Stephan R (2011). "Omeprazole MUPS®: An Advanced Formulation offering Flexibility and Predictability for Self Medication". SelfCare Journal. 2. Archived from the original on 2016-06-11. สืบค้นเมื่อ 2016-06-11.CS1 maint: Uses authors parameter (link)
  51. ↑ "Santarus Receives FDA Approval for Immediate-Release Omeprazole Tablet with Dual Buffers". Santarus (Press release). 2009-12-04. Archived from the original on 2014-04-18.

แหล่งที่มา

WikiPedia: โอมีปราโซล http://www.drugbank.ca/drugs/DB00338#pharmacology http://www1.astrazeneca-us.com/pi/Prilosec.pdf http://www.chemspider.com/Chemical-Structure.4433.... http://www.medicinescomplete.com/mc/martindale/cur... http://emedicine.medscape.com/article/1879354-over... http://www.medscape.com/viewarticle/508018 http://www.mims.com/malaysia/drug/info/omeprazole/... http://www.rxlist.com/zegerid-drug-patient.htm http://ir.santarus.com/common/mobile/iphone/releas... http://selfcarejournal.com/article/omeprazole-mups...